The ICOS (Vopratelimab) Biosimilar MAb (HDBS0012) is a monoclonal antibody designed for research involving the ICOS protein, a key immune checkpoint molecule that plays a crucial role in regulating T-cell activation and immune response. This biosimilar antibody, with high specificity and affinity for ICOS, is optimized for use in various applications such as flow cytometry, immunohistochemistry, and ELISA.ICOS, also known as inducible T-cell co-stimulator, is a costimulatory molecule that is essential for T-cell activation and differentiation, making it a promising target for cancer immunotherapy and autoimmune disease research.
By blocking or activating ICOS signaling pathways, researchers can manipulate immune responses to enhance anti-tumor immunity or suppress autoimmune reactions.The Anti-ICOS (Vopratelimab) Biosimilar MAb (HDBS0012) provides a valuable tool for investigating the role of ICOS in immune regulation and disease pathogenesis. Its high specificity and reliability make it an ideal choice for studies exploring the therapeutic potential of targeting ICOS in various clinical settings. Order now to advance your research in immunology and oncology.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
JTX-2011
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
